TOP TIERMARKET NEWSWIRE
News & sentiment

JAZZ PHARMACEUTICALS (JAZZ) — News & AI sentiment

JAZZ PHARMACEUTICALS (JAZZ) news roundup. 3 stories in the last 24 hours, 6 in the past week, 17 over 30 days. Average 24-hour sentiment is 63.7/100 — bullish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 7 sales totalling $24.9M — net selling of $24.9M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
3
avg sentiment 63.7/100
7d stories
6
avg sentiment 52.2/100
30d stories
17
avg sentiment 55.4/100
Insider net (90d)
$24.9M
0 buys · 7 sells
Congress (90d)
0
0 buys · 0 sells

JAZZ news in the last 24 hours, 7 days, 30 days and 90 days

How much JAZZ coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowJAZZ storiesAvg AI sentimentRead
Last 24 hours363.7/100JAZZ headlines →
Last 7 days652.2/100JAZZ headlines →
Last 30 days1755.4/100JAZZ headlines →
Last 90 days8558.4/100JAZZ headlines →

Latest stories on JAZZ

4h ago
5h ago
20h ago
2d ago
2d ago
2d ago
Oct 19
Oct 15
Oct 14
Oct 9
Oct 9
Oct 9
Oct 8
Oct 7
Oct 6
Sep 30
Sep 30
Goldman Sachs initiates Jazz Pharmaceuticals stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 24
Sep 24
Sep 23
Sep 23
Sep 18
Sep 18
Sep 18
Sep 16
Open JAZZ in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →